Acute Interstitial Nephritis Withdrawn Phase 2 Trials for Omalizumab (DB00043)

Also known as: Interstitial nephritis acute / Acute infectious interstitial nephritis / Nephritis interstitial acute / Tubulointerstitial nephritis / Nephritis, Tubulointerstitial

IndicationStatusPhase
DBCOND0065030 (Acute Interstitial Nephritis)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01893658Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)Treatment